Free Trial

Advisors Preferred LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Advisors Preferred LLC purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,640 shares of the company's stock, valued at approximately $427,000.

A number of other institutional investors have also recently made changes to their positions in the company. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new position in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in Clorox during the third quarter worth approximately $48,000. Finally, Friedenthal Financial purchased a new position in Clorox during the third quarter worth approximately $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and lifted their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Evercore ISI lifted their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Finally, Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $158.21.

Get Our Latest Stock Analysis on CLX

Clorox Stock Up 0.2 %

Shares of CLX traded up $0.30 during mid-day trading on Wednesday, reaching $148.66. The company's stock had a trading volume of 842,689 shares, compared to its average volume of 1,340,792. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market cap of $18.40 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The company's 50 day moving average is $160.30 and its 200 day moving average is $159.26.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company posted $2.16 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.28%. Clorox's dividend payout ratio is presently 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines